chitosan has been researched along with amphotericin b in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (4.00) | 29.6817 |
| 2010's | 38 (76.00) | 24.3611 |
| 2020's | 10 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Limpeanchob, N; Tiyaboonchai, W | 1 |
| Buranapanitkit, B; Krisanapiboon, A; Oungbho, K | 1 |
| Amini, M; Fazeli, MR; Gilani, K; Jamalifar, H; Moazeni, E; Ramezanli, T | 1 |
| Albasarah, YY; Somavarapu, S; Stapleton, P; Taylor, KM | 1 |
| Conesa, A; Gebbia, M; Giaever, G; Heisler, LE; Jaime, MD; Lee, AY; Lopez-Llorca, LV; Nislow, C; Proctor, M; Westwood, JT | 1 |
| Fallah, AA; Kousha, S; Saei-Dehkordi, SS | 1 |
| Asthana, S; Chourasia, MK; Dube, A; Gupta, PK; Jaiswal, AK; Pawar, VK | 1 |
| Rana, V; Singh, K; Tiwary, AK | 1 |
| Jian, J; Song, S; Wang, Y; Zhou, W | 1 |
| Abánades, DR; Andrade, PH; Arruda, LV; Castilho, RO; Chávez-Fumagalli, MA; Coelho, EA; Costa, LE; Duarte, MC; Faraco, AA; França, JR; Lage, DP; Lage, PS; Martins, VT; Ribeiro, TG; Rodrigues, LB; Tavares, CA; Valadares, DG | 1 |
| Asthana, S; Chourasia, MK; Dube, A; Gupta, A; Jain, V; Jaiswal, AK; Pawar, VK | 1 |
| Beenken, KE; Bumgardner, JD; Haggard, WO; Hittle, L; Jennings, JA; Parker, AC; Shirtliff, ME; Smeltzer, MS | 1 |
| Asthana, S; Dube, A; Dwivedi, P; Gupta, PK; Jaiswal, AK; Kumar, V; Mishra, PR; Shukla, P; Verma, A | 1 |
| Cardoso, VN; Castilho, RO; Chávez-Fumagalli, MA; Coelho, EA; Costa, LE; Duarte, MC; Faraco, AA; Fernandes, SO; Franca, JR; Fuscaldi, LL; Lage, PS; Martins, VT; Ribeiro, TG; Santos, ML; Soto, M; Tavares, CA | 1 |
| Bhatta, RS; Chandasana, H; Chhonker, YS; Mitra, K; Prasad, YD; Shukla, PK; Vishvkarma, A | 1 |
| Bera, T; Bhatia, S; Kumar, V; Nagpal, K; Sharma, K | 1 |
| Bumgardner, JD; Haggard, WO; Hittle, L; Jennings, JA; Parker, AC; Rhodes, C; Shirtliff, M | 1 |
| Cejkova, A; Kvasnickova, E; Masak, J; Matatkova, O | 1 |
| Dube, A; Dwivedi, P; Jaiswal, AK; Khatik, R; Mishra, PR; Shukla, P; Tripathi, P | 1 |
| Bodas, D; Ghormade, V; Kamat, V; Marathe, I; Paknikar, K | 1 |
| Bose, PP; Dwivedi, MK; Kumar, P | 1 |
| Fu, T; Lv, S; Yi, J; Zhang, B | 1 |
| Ježdík, R; Kvasničková, E; Masák, J; Maťátková, O; Paldrychová, M; Paulíček, V | 1 |
| Akhtar, S; Edagwa, BJ; Gendelman, HE; McMillan, J; Qureshi, NA; Raza, A; Shahnaz, G; Yasinzai, M | 1 |
| Bories, C; Bouchemal, K; Grisin, T; Loiseau, PM | 1 |
| Bombardi, M; Bories, C; Bouchemal, K; Grisin, T; Loiseau, PM; Mallet, JM; Ponchel, G; Rouffiac, V; Solgadi, A | 1 |
| Dube, A; Jaiswal, AK; Mishra, PR; Tripathi, P | 1 |
| Bora, HK; Chaurasia, M; Chourasia, MK; Dube, A; Gayen, JR; Jaiswal, AK; Meher, JG; Pawar, VK; Raval, K; Singh, PK; Singh, Y; Srikanth, CH | 1 |
| Maneesha K, S; R, J; Raja, B; S, S; Sandhya, M; V, A | 1 |
| Akhtar, S; Gendelman, HE; Nadhman, A; Rehman, AU; Saljoughian, N; Sarwar, HS; Satoskar, AR; Shahnaz, G; Sohail, MF; Yasinzai, M | 1 |
| Auler, ME; de Camargo, LEA; Khalil, NM; Ludwig, DB; Mainardes, RM | 1 |
| Billa, N; Ling Tan, JS; Roberts, CJ | 1 |
| Jain, S; Kushwah, V; Reddy, CSK; Swami, R | 1 |
| Dandekar, P; Jain, R; Krishnan, RA; Pant, T; Sankaranarayan, S; Stenberg, J | 1 |
| Khalil, NM; Mainardes, RM; Pedroso, LS; Tominaga, TT; Vásquez Marcano, RGDJ | 1 |
| Deng, P; Feng, R; Feng, S; Song, Z; Teng, F; Wen, Y; Xu, H; Zhou, F; Zhu, L | 1 |
| Ardestani, MS; Khamesipour, A; Mehrizi, TZ; Molla Hoseini, MH; Mosaffa, N; Ramezani, A | 1 |
| Billa, N; Ling, JTS; Roberts, CJ | 1 |
| Billa, N; Roberts, C; Tan, JSL | 1 |
| Ebrahimi Shahmabadi, H; Haji Molla Hoseini, M; Khamesipour, A; Mosaffa, N; Ramezani, A; Shafiee Ardestani, M; Zadeh Mehrizi, T | 1 |
| Croft, SL; Murdan, S; Raynes, JG; Riezk, A; Yardley, V | 1 |
| Aam, BB; Eijsink, VGH; Ganan, M; Gaustad, P; Lorentzen, SB; Sørlie, M | 1 |
| Croft, SL; Loiseau, PM; Pomel, S | 1 |
| Chang, CJ; Deng, FS; Lin, CH; Lo, WH | 1 |
| Ardestani, MS; Mehrizi, TZ; Ramezani, A; Rezayat, SM; Shahmabadi, HE | 1 |
| Alishahi, M; Asgari, Q; Barzegar, S; Caravan, D; Davani, F; Enjavi, Y; Esfandiari, F; Khorram, M; Zomorodian, K | 1 |
| Kushwaha, AK; Mudavath, SL; Negi, M; Singh, A; Singh, OP; Sundar, S; Yadagiri, G | 1 |
| Çetin Uyanikgil, EÖ; Gürbüz Çolak, N; Özbel, Y; Töz, S | 1 |
| Amirzadeh, N; Ardekani, NT; Barzegar, A; Iraji, A; Irajie, C; Jafari, M; Khorram, M; Nouraei, H; Pakshir, K; Tamaddon, AM; Zareshahrabadi, Z; Zomorodian, K | 1 |
| Howattanapanich, S; Matangkasombut, O; Satitviboon, W; Thanyasrisung, P | 1 |
2 review(s) available for chitosan and amphotericin b
| Article | Year |
|---|---|
Chitosan Contribution to Therapeutic and Vaccinal Approaches for the Control of Leishmaniasis.
Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Betulinic Acid; Biocompatible Materials; Chitosan; Curcumin; Drug Carriers; Drug Compounding; Humans; Hydrogen-Ion Concentration; Leishmaniasis; Leishmaniasis Vaccines; Macrophages; Nanoparticles; Paromomycin; Pentacyclic Triterpenes; Polymers; Rifampin; Selenium; Thiomalates; Titanium; Triterpenes; Ursolic Acid | 2020 |
A Review Study about the Effect of Chitosan Nanocarrier on Improving the Efficacy of Amphotericin B in the Treatment of Leishmania from 2010 to 2020.
Topics: Amphotericin B; Antiprotozoal Agents; Chitosan; Drug Carriers; Leishmania; Nanoparticles | 2021 |
48 other study(ies) available for chitosan and amphotericin b
| Article | Year |
|---|---|
Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles.
Topics: Amphotericin B; Animals; Chitosan; Dextran Sulfate; Drug Delivery Systems; Male; Mice; Mice, Inbred ICR; Nanomedicine; Nanoparticles | 2007 |
Biocompatability of hydroxyapatite composite as a local drug delivery system.
Topics: Amphotericin B; Biocompatible Materials; Calcium Sulfate; Chitosan; Drug Delivery Systems; Durapatite; Fosfomycin; Gentamicins; Humans; Imipenem; Osteoblasts | 2006 |
Development of respirable nanomicelle carriers for delivery of amphotericin B by jet nebulization.
Topics: Administration, Inhalation; Amphotericin B; Antifungal Agents; Chemical Phenomena; Chitosan; Cross-Linking Reagents; Drug Carriers; Drug Compounding; Drug Delivery Systems; Micelles; Microbial Sensitivity Tests; Mitosporic Fungi; Nanostructures; Nebulizers and Vaporizers; Particle Size; Solubility; Stearic Acids | 2011 |
Chitosan-coated antifungal formulations for nebulisation.
Topics: Administration, Inhalation; Amphotericin B; Antifungal Agents; Candida; Chemistry, Pharmaceutical; Chitosan; Liposomes; Micelles; Microbial Sensitivity Tests; Nebulizers and Vaporizers | 2010 |
Identification of yeast genes that confer resistance to chitosan oligosaccharide (COS) using chemogenomics.
Topics: Amphotericin B; Antifungal Agents; Cell Membrane Permeability; Chitosan; Drug Resistance, Fungal; Fluconazole; Gene Expression Profiling; Gene Expression Regulation, Fungal; Haploinsufficiency; Monomeric GTP-Binding Proteins; Naphthalenes; Oxidative Stress; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Terbinafine; Vesicular Transport Proteins | 2012 |
Chemical composition and antioxidative activity of Echinophora platyloba DC. essential oil, and its interaction with natural antimicrobials against food-borne pathogens and spoilage organisms.
Topics: Acyclic Monoterpenes; Amphotericin B; Anti-Infective Agents; Antioxidants; Apiaceae; beta Carotene; Biphenyl Compounds; Chitosan; Cymenes; Drug Interactions; Drug Resistance, Multiple, Bacterial; Food Contamination; Food Microbiology; Gas Chromatography-Mass Spectrometry; Gram-Negative Bacteria; Gram-Positive Bacteria; Laurates; Linoleic Acid; Microbial Sensitivity Tests; Monoglycerides; Monoterpenes; Nisin; Oils, Volatile; Picrates; Plant Oils; Thymol | 2012 |
Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsules.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Chitosan; Cricetinae; Leishmaniasis, Visceral; Male; Nanocapsules | 2013 |
Spray dried chitosan-EDTA superior microparticles as solid substrate for the oral delivery of amphotericin B.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Antiprotozoal Agents; Calorimetry, Differential Scanning; Chitosan; Desiccation; Drug Carriers; Drug Compounding; Edetic Acid; Emulsions; In Vitro Techniques; Intestinal Absorption; Intestine, Small; Microspheres; Sus scrofa; Thermodynamics | 2013 |
Self-aggregated nanoparticles based on amphiphilic poly(lactic acid)-grafted-chitosan copolymer for ocular delivery of amphotericin B.
Topics: Acrylic Resins; Administration, Ophthalmic; Amphotericin B; Animals; Antifungal Agents; Candida; Cell Survival; Chitosan; Crystallization; Diffusion; Drug Compounding; Eye Infections, Fungal; Hydrophobic and Hydrophilic Interactions; Nanocapsules; Particle Size; Rabbits | 2013 |
Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system.
Topics: Amphotericin B; Animals; Chemistry, Pharmaceutical; Chitosan; Chondroitin Sulfates; Drug Delivery Systems; Female; Humans; Leishmania infantum; Leishmania mexicana; Leishmaniasis; Macrophages; Mice; Mice, Inbred BALB C; Nanomedicine; Nanoparticles; Trypanocidal Agents | 2014 |
Chitosan-assisted immunotherapy for intervention of experimental leishmaniasis via amphotericin B-loaded solid lipid nanoparticles.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Chitosan; Emulsions; Immunotherapy; Leishmania donovani; Leishmaniasis, Visceral; Lipids; Mice; Nanoparticles | 2014 |
Characterization of local delivery with amphotericin B and vancomycin from modified chitosan sponges and functional biofilm prevention evaluation.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Biofilms; Chitosan; Drug Delivery Systems; Mice; Musculoskeletal System; Polyethylene Glycols; Porifera; Vancomycin | 2015 |
Self assembled ionically sodium alginate cross-linked amphotericin B encapsulated glycol chitosan stearate nanoparticles: applicability in better chemotherapy and non-toxic delivery in visceral leishmaniasis.
Topics: Alginates; Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Chitosan; Drug Carriers; Glucuronic Acid; Hexuronic Acids; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Male; Mesocricetus; Nanoparticles; Rats, Wistar; Stearates | 2015 |
An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Chitosan; Chondroitin Sulfates; Female; Kidney; Leishmania; Leishmaniasis; Mice; Mice, Inbred BALB C; Nanoparticles; Tissue Distribution | 2014 |
Amphotericin-B entrapped lecithin/chitosan nanoparticles for prolonged ocular application.
Topics: Adhesiveness; Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Chemistry, Pharmaceutical; Chitosan; Drug Delivery Systems; Drug Stability; Eye; Instillation, Drug; Lecithins; Male; Nanoparticles; Nephelometry and Turbidimetry; Rabbits; Spectroscopy, Fourier Transform Infrared; Static Electricity | 2015 |
Significance of algal polymer in designing amphotericin B nanoparticles.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Chitosan; Drug Carriers; Humans; Hydrogen-Ion Concentration; Nanoparticles; Polymers; Sepharose | 2014 |
Preliminary evaluation of local drug delivery of amphotericin B and in vivo degradation of chitosan and polyethylene glycol blended sponges.
Topics: Amphotericin B; Animals; Candida albicans; Candidiasis; Chitosan; Drug Delivery Systems; Drug Evaluation, Preclinical; Male; Polyethylene Glycols; Rats; Rats, Sprague-Dawley | 2016 |
Evaluation of baicalein, chitosan and usnic acid effect on Candida parapsilosis and Candida krusei biofilm using a Cellavista device.
Topics: Amphotericin B; Anti-Infective Agents; Benzofurans; Biofilms; Candida; Chitosan; Flavanones; Humans; Image Processing, Computer-Assisted; Microbial Sensitivity Tests; Microscopy | 2015 |
Development of 4-sulfated N-acetyl galactosamine anchored chitosan nanoparticles: A dual strategy for effective management of Leishmaniasis.
Topics: Acetylgalactosamine; Amphotericin B; Animals; Cell Line; Chitosan; Chromatography, High Pressure Liquid; Leishmaniasis; Macrophages; Mice; Microscopy, Electron, Transmission; Nanoparticles; Spectroscopy, Fourier Transform Infrared; Sulfates | 2015 |
Synthesis of Monodisperse Chitosan Nanoparticles and in Situ Drug Loading Using Active Microreactor.
Topics: Amphotericin B; Antifungal Agents; Candida; Chitosan; Computer Simulation; Drug Liberation; Endocytosis; Humans; Materials Testing; MCF-7 Cells; Microbial Sensitivity Tests; Nanoparticles; Nanotechnology; Particle Size; Spectroscopy, Fourier Transform Infrared | 2015 |
Hemoglobin guided nanocarrier for specific delivery of amphotericin B to Leishmania infected macrophage.
Topics: Amphotericin B; Cells, Cultured; Chitosan; Chondroitin Sulfates; Drug Carriers; Hemoglobins; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Nanoparticles | 2016 |
Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
Topics: Administration, Ophthalmic; Amphotericin B; Animals; Antifungal Agents; Biological Availability; Chitosan; Delayed-Action Preparations; Drug Compounding; Emulsions; Eye Infections, Fungal; Keratitis; Lipids; Liposomes; Male; Nanoparticles; Particle Size; Permeability; Rabbits | 2017 |
Aspergillus fumigatus DBM 4057 biofilm formation is inhibited by chitosan, in contrast to baicalein and rhamnolipid.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Biofilms; Chitosan; Flavanones; Glycolipids; Microbial Sensitivity Tests | 2016 |
Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Chitosan; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mannose; Mice; Nanoparticles | 2017 |
Cyclodextrin-mediated self-associating chitosan micro-platelets act as a drug booster against Candida glabrata mucosal infection in immunocompetent mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Chitosan; Cyclodextrins; Deoxycholic Acid; Drug Combinations; Immunocompromised Host; Mice; Mucous Membrane | 2017 |
Supramolecular Chitosan Micro-Platelets Synergistically Enhance Anti-Candida albicans Activity of Amphotericin B Using an Immunocompetent Murine Model.
Topics: alpha-Cyclodextrins; Amphotericin B; Animals; Antifungal Agents; Blood Platelets; Candida albicans; Candidiasis; Chemistry, Pharmaceutical; Chitosan; Deoxycholic Acid; Disease Models, Animal; Drug Combinations; Female; Hydrogels; Mice; Mice, Inbred BALB C; Mucous Membrane; Nanoparticles; Poloxamer; Swine | 2017 |
Hexadecylphosphocholine (Miltefosine) stabilized chitosan modified Ampholipospheres as prototype co-delivery vehicle for enhanced killing of L. donovani.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Chitosan; Drug Carriers; Drug Stability; Leishmania donovani; Macrophages; Nanoparticles; Phosphorylcholine; Rats; Rats, Wistar; Tissue Distribution | 2017 |
Chitosan coated PluronicF127 micelles for effective delivery of Amphotericin B in experimental visceral leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Chitosan; Cricetinae; Cytokines; Drug Carriers; Drug Compounding; Female; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mice; Micelles; Poloxamer; Tissue Distribution | 2017 |
Amphotericin B loaded sulfonated chitosan nanoparticles for targeting macrophages to treat intracellular Candida glabrata infections.
Topics: Amphotericin B; Animals; Candida glabrata; Candidiasis; Chitosan; Drug Delivery Systems; Macrophages; Mice; Nanoparticles; RAW 264.7 Cells | 2018 |
Design of mannosylated oral amphotericin B nanoformulation: efficacy and safety in visceral leishmaniasis.
Topics: Adhesiveness; Administration, Oral; Amphotericin B; Animals; Biological Availability; Cell Membrane; Chitosan; Drug Carriers; Drug Compounding; Immunomodulation; Leishmaniasis, Visceral; Mannose; Mice; Nanoparticles; Nitric Oxide; Particle Size; Permeability; Safety; Tissue Distribution | 2018 |
Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidemia; Candidiasis, Vulvovaginal; Chitosan; Drug Carriers; Female; Humans; Lactic Acid; Microbial Sensitivity Tests; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Trichosporon; Urinary Tract Infections | 2018 |
Mucoadhesive chitosan-coated nanostructured lipid carriers for oral delivery of amphotericin B.
Topics: Adhesives; Administration, Oral; Amphotericin B; Anti-Bacterial Agents; Chitosan; Drug Carriers; Lipids; Nanostructures | 2019 |
Amphotericin B Loaded Chitosan Nanoparticles: Implication of Bile Salt Stabilization on Gastrointestinal Stability, Permeability and Oral Bioavailability.
Topics: Administration, Oral; Amphotericin B; Animals; Bile Acids and Salts; Biological Availability; Caco-2 Cells; Chitosan; Humans; Nanoparticles; Permeability | 2018 |
Protective nature of low molecular weight chitosan in a chitosan-Amphotericin B nanocomplex - A physicochemical study.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Chitosan; CHO Cells; Cricetulus; Molecular Weight; Nanostructures | 2018 |
Chitosan functionalized poly (ε-caprolactone) nanoparticles for amphotericin B delivery.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida parapsilosis; Cell Survival; Chitosan; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Erythrocytes; Healthy Volunteers; Humans; Microbial Sensitivity Tests; Nanoparticles; Particle Size; Polyesters; Vero Cells | 2018 |
Linolenic acid-modified methoxy poly (ethylene glycol)-oligochitosan conjugate micelles for encapsulation of amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Chitin; Chitosan; Drug Carriers; Drug Liberation; Erythrocytes; Hemolysis; Kidney; Linolenic Acids; Male; Mice; Micelles; Oligosaccharides; Polyethylene Glycols; Polymers; Rats, Sprague-Dawley | 2019 |
Novel nano-sized chitosan amphotericin B formulation with considerable improvement against Leishmania major.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Chitosan; Drug Carriers; Drug Liberation; Female; Leishmania major; Mice, Inbred BALB C; Nanoparticles; Particle Size; Solvents; Surface Properties | 2018 |
Antifungal and Mucoadhesive Properties of an Orally Administered Chitosan-Coated Amphotericin B Nanostructured Lipid Carrier (NLC).
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Chitosan; Drug Carriers; Erythrocytes; HT29 Cells; Humans; Intestinal Mucosa; Jejunum; Lipids; Male; Microbial Sensitivity Tests; Nanostructures; Rats, Sprague-Dawley | 2019 |
Pharmacokinetics and tissue distribution of an orally administered mucoadhesive chitosan-coated amphotericin B-Loaded nanostructured lipid carrier (NLC) in rats.
Topics: Adhesiveness; Administration, Oral; Amphotericin B; Animals; Chitosan; Drug Carriers; Drug Compounding; Lipids; Male; Mucous Membrane; Nanostructures; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2020 |
Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Betulinic Acid; Cell Survival; Chitosan; Dendrimers; Drug Delivery Systems; Drug Liberation; Leishmania major; Molecular Docking Simulation; Nanoparticles; Parasites; Pentacyclic Triterpenes; Real-Time Polymerase Chain Reaction; Solubility; Thermodynamics; Triterpenes | 2019 |
Activity of Chitosan and Its Derivatives against Leishmania major and Leishmania mexicana
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Chitosan; Culture Media; Dose-Response Relationship, Drug; Female; Humans; Hydrogen-Ion Concentration; Leishmania major; Leishmania mexicana; Life Cycle Stages; Macrophages; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Molecular Weight; Nitric Oxide; Parasitic Sensitivity Tests; Pinocytosis; Primary Cell Culture; Reactive Oxygen Species; THP-1 Cells; Tumor Necrosis Factor-alpha | 2020 |
Antibiotic saving effect of combination therapy through synergistic interactions between well-characterized chito-oligosaccharides and commercial antifungals against medically relevant yeasts.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chitosan; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Fluconazole; Humans; Microbial Sensitivity Tests; Polymerization; Proton Magnetic Resonance Spectroscopy | 2019 |
Synergistic Antifungal Activity of Chitosan with Fluconazole against
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candida tropicalis; Chitosan; Drug Resistance, Fungal; Fluconazole | 2020 |
Fabrication of amphotericin B-loaded electrospun core-shell nanofibers as a novel dressing for superficial mycoses and cutaneous leishmaniasis.
Topics: Amphotericin B; Bandages; Chitosan; Humans; Leishmaniasis, Cutaneous; Nanofibers | 2021 |
Carboxymethyl chitosan modified lipid nanoformulations as a highly efficacious and biocompatible oral anti-leishmanial drug carrier system.
Topics: Amphotericin B; Antiprotozoal Agents; Chitosan; Drug Carriers; Lipids; Nanoparticles | 2022 |
The Designing of a Gel Formulation with Chitosan Polymer Using Liposomes as Nanocarriers of Amphotericin B for a Non-invasive Treatment Model of Cutaneous Leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Chitosan; Female; Gels; Humans; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Liposomes; Mice; Mice, Inbred BALB C; Polymers | 2022 |
Magnetic chitosan nanoparticles loaded with Amphotericin B: Synthesis, properties and potentiation of antifungal activity against common human pathogenic fungal strains.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Chitosan; Hemolysis; Humans; Magnetic Phenomena; Nanoparticles; Spectroscopy, Fourier Transform Infrared | 2022 |
Antifungal drug resistance in oral Candida isolates from HIV-infected and healthy individuals and efficacy of chitosan as an alternative antifungal agent.
Topics: Amphotericin B; Antifungal Agents; Candida; Chitosan; Drug Resistance, Fungal; Fluconazole; HIV Infections; Humans; Microbial Sensitivity Tests | 2023 |